Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Jun 16, 2020 3:47pm
58 Views
Post# 31157185

RE:RE:11:10 a.m. today, see agn, post there re: peptides???

RE:RE:11:10 a.m. today, see agn, post there re: peptides???because covid-19 is a virus causing blood vessel infections

https://elemental.medium.com/coronavirus-may-be-a-blood-vessel-disease-which-explains-everything-2c4032481ab2

and watch this doctor arguing that covid-19 is a vascular problem
https://www.youtube.com/watch?v=W1eH6DYQ1ro

I rather have an e-selectin binding agent that can moderate the infected endothelium of the blood vessels, minimizing inflammation and limit the call up of white blood cells



90guppy wrote: did you mean metablok of arch biopartners? It is an interesting enzyme, a dipeptidase-1 inhibitor. Ok, it can can control inflammation in lungs, kidney and liver. But the inflamed tissue of those organ are not the problem to be solved. What is to be solved is the inflamed or infected blood vessels present within those organs. Maybe it will work but the inflamed endothelial cells showing the specific inflamation marker called e-selectin is still very much present and sending signal to the immune system to send the white blood cells. Metablok may work, but I rather have an agent particularly targeting the infected blood vessels.

bigbanktheory wrote: 90guppy, any comments, glta




<< Previous
Bullboard Posts
Next >>